APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Artemisinin

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

Selected research

Market Analysis & Forecast

Global Artemisinin Market Analysis and Forecast 2026-2032

21 December 2025217 pages

Choose your research edition.

Industry ResearchArtemisinin Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Artemisinin Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Artemisinin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artemisinin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Artemisinin Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.

Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.

Read the full market overview

In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 80%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.

This report presents an overview of global market for Artemisinin, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Artemisinin, also provides the consumption of main regions and countries. Of the upcoming market potential for Artemisinin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artemisinin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artemisinin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Artemisinin sales, projected growth trends, production technology, application and end-user industry.

Artemisinin Segment by Company

Sanofi

KPC Pharmaceuticals

Kerui nanhai

Guangxi xiancaotang

Guilin Pharmaceutical

Natural Bio-engineering

BIONEXX

CAT KHANH

BEEPZ

Novanat Bioresource

Artemisinin Segment by Type

Extraction From Artemisia Annua

Semisynthetic Artemisinin

Artemisinin Segment by Application

Antimalarial Injections

Antimalarial Tablets

Artemisinin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artemisinin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Artemisinin production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Artemisinin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Artemisinin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artemisinin sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artemisinin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Extraction From Artemisia Annua Major Manufacturers Table 3. Semisynthetic Artemisinin Major Manufacturers Table 4. Global Artemisinin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Antimalarial Injections Major Manufacturers Table 6. Antimalarial Tablets Major Manufacturers Table 7. Artemisinin Industry Trends Table 8. Artemisinin Industry Drivers Table 9. Artemisinin Industry Opportunities and Challenges Table 10. Artemisinin Industry Restraints Table 11. Global Artemisinin Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (MT) Table 12. Global Artemisinin Production by Region (2021-2026) & (MT) Table 13. Global Artemisinin Production by Region (2027-2032) & (MT) Table 14. Global Artemisinin Production Market Share by Region (2021-2026) Table 15. Global Artemisinin Production Market Share by Region (2027-2032) Table 16. Global Artemisinin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Artemisinin Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Artemisinin Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Artemisinin Revenue Market Share by Region (2021-2026) Table 20. Global Artemisinin Revenue Market Share by Region (2027-2032) Table 21. Global Artemisinin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (MT) Table 22. Global Artemisinin Sales by Region (2021-2026) & (MT) Table 23. Global Artemisinin Sales by Region (2027-2032) & (MT) Table 24. Global Artemisinin Sales Market Share by Region (2021-2026) Table 25. Global Artemisinin Sales Market Share by Region (2027-2032) Table 26. Global Artemisinin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Artemisinin Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Artemisinin Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Artemisinin Sales Market Share by Manufacturers (2021-2026) Table 30. Global Artemisinin Sales Price (USD/MT) of Manufacturers (2021-2026) Table 31. Global Artemisinin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Artemisinin Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Artemisinin Manufacturers, Product Type & Application Table 34. Global Artemisinin Manufacturers Commercialization Time Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Artemisinin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 37. Global Artemisinin Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Artemisinin Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Artemisinin Revenue Market Share by Type (2021-2026) Table 40. Global Artemisinin Revenue Market Share by Type (2027-2032) Table 41. Global Artemisinin Sales by Type (2021-2026) & (MT) Table 42. Global Artemisinin Sales by Type (2027-2032) & (MT) Table 43. Global Artemisinin Sales Market Share by Type (2021-2026) Table 44. Global Artemisinin Sales Market Share by Type (2027-2032) Table 45. Global Artemisinin Price by Type (2021-2026) & (USD/MT) Table 46. Global Artemisinin Price by Type (2027-2032) & (USD/MT) Table 47. Global Artemisinin Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Artemisinin Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Artemisinin Revenue Market Share by Application (2021-2026) Table 50. Global Artemisinin Revenue Market Share by Application (2027-2032) Table 51. Global Artemisinin Sales by Application (2021-2026) & (MT) Table 52. Global Artemisinin Sales by Application (2027-2032) & (MT) Table 53. Global Artemisinin Sales Market Share by Application (2021-2026) Table 54. Global Artemisinin Sales Market Share by Application (2027-2032) Table 55. Global Artemisinin Price by Application (2021-2026) & (USD/MT) Table 56. Global Artemisinin Price by Application (2027-2032) & (USD/MT) Table 57. Sanofi Company Information Table 58. Sanofi Business Overview Table 59. Sanofi Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 60. Sanofi Artemisinin Product Portfolio Table 61. Sanofi Recent Development Table 62. KPC Pharmaceuticals Company Information Table 63. KPC Pharmaceuticals Business Overview Table 64. KPC Pharmaceuticals Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 65. KPC Pharmaceuticals Artemisinin Product Portfolio Table 66. KPC Pharmaceuticals Recent Development Table 67. Kerui nanhai Company Information Table 68. Kerui nanhai Business Overview Table 69. Kerui nanhai Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 70. Kerui nanhai Artemisinin Product Portfolio Table 71. Kerui nanhai Recent Development Table 72. Guangxi xiancaotang Company Information Table 73. Guangxi xiancaotang Business Overview Table 74. Guangxi xiancaotang Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 75. Guangxi xiancaotang Artemisinin Product Portfolio Table 76. Guangxi xiancaotang Recent Development Table 77. Guilin Pharmaceutical Company Information Table 78. Guilin Pharmaceutical Business Overview Table 79. Guilin Pharmaceutical Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 80. Guilin Pharmaceutical Artemisinin Product Portfolio Table 81. Guilin Pharmaceutical Recent Development Table 82. Natural Bio-engineering Company Information Table 83. Natural Bio-engineering Business Overview Table 84. Natural Bio-engineering Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 85. Natural Bio-engineering Artemisinin Product Portfolio Table 86. Natural Bio-engineering Recent Development Table 87. BIONEXX Company Information Table 88. BIONEXX Business Overview Table 89. BIONEXX Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 90. BIONEXX Artemisinin Product Portfolio Table 91. BIONEXX Recent Development Table 92. CAT KHANH Company Information Table 93. CAT KHANH Business Overview Table 94. CAT KHANH Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 95. CAT KHANH Artemisinin Product Portfolio Table 96. CAT KHANH Recent Development Table 97. BEEPZ Company Information Table 98. BEEPZ Business Overview Table 99. BEEPZ Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 100. BEEPZ Artemisinin Product Portfolio Table 101. BEEPZ Recent Development Table 102. Novanat Bioresource Company Information Table 103. Novanat Bioresource Business Overview Table 104. Novanat Bioresource Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 105. Novanat Bioresource Artemisinin Product Portfolio Table 106. Novanat Bioresource Recent Development Table 107. North America Artemisinin Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Artemisinin Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Artemisinin Sales by Type (2021-2026) & (MT) Table 110. North America Artemisinin Sales by Type (2027-2032) & (MT) Table 111. North America Artemisinin Sales Price by Type (2021-2026) & (USD/MT) Table 112. North America Artemisinin Sales Price by Type (2027-2032) & (USD/MT) Table 113. North America Artemisinin Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Artemisinin Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Artemisinin Sales by Application (2021-2026) & (MT) Table 116. North America Artemisinin Sales by Application (2027-2032) & (MT) Table 117. North America Artemisinin Sales Price by Application (2021-2026) & (USD/MT) Table 118. North America Artemisinin Sales Price by Application (2027-2032) & (USD/MT) Table 119. North America Artemisinin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Artemisinin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Artemisinin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Artemisinin Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 123. North America Artemisinin Sales by Country (2021-2026) & (MT) Table 124. North America Artemisinin Sales by Country (2027-2032) & (MT) Table 125. North America Artemisinin Sales Price by Country (2021-2026) & (USD/MT) Table 126. North America Artemisinin Sales Price by Country (2027-2032) & (USD/MT) Table 127. United States Artemisinin Revenue (2021-2032) & (US$ Million) Table 128. Canada Artemisinin Revenue (2021-2032) & (US$ Million) Table 129. Mexico Artemisinin Revenue (2021-2032) & (US$ Million) Table 130. Europe Artemisinin Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Artemisinin Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Artemisinin Sales by Type (2021-2026) & (MT) Table 133. Europe Artemisinin Sales by Type (2027-2032) & (MT) Table 134. Europe Artemisinin Sales Price by Type (2021-2026) & (USD/MT) Table 135. Europe Artemisinin Sales Price by Type (2027-2032) & (USD/MT) Table 136. Europe Artemisinin Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Artemisinin Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Artemisinin Sales by Application (2021-2026) & (MT) Table 139. Europe Artemisinin Sales by Application (2027-2032) & (MT) Table 140. Europe Artemisinin Sales Price by Application (2021-2026) & (USD/MT) Table 141. Europe Artemisinin Sales Price by Application (2027-2032) & (USD/MT) Table 142. Europe Artemisinin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Artemisinin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Artemisinin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Artemisinin Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 146. Europe Artemisinin Sales by Country (2021-2026) & (MT) Table 147. Europe Artemisinin Sales by Country (2027-2032) & (MT) Table 148. Europe Artemisinin Sales Price by Country (2021-2026) & (USD/MT) Table 149. Europe Artemisinin Sales Price by Country (2027-2032) & (USD/MT) Table 150. Germany Artemisinin Revenue (2021-2032) & (US$ Million) Table 151. France Artemisinin Revenue (2021-2032) & (US$ Million) Table 152. U.K. Artemisinin Revenue (2021-2032) & (US$ Million) Table 153. Italy Artemisinin Revenue (2021-2032) & (US$ Million) Table 154. Russia Artemisinin Revenue (2021-2032) & (US$ Million) Table 155. Spain Artemisinin Revenue (2021-2032) & (US$ Million) Table 156. Netherlands Artemisinin Revenue (2021-2032) & (US$ Million) Table 157. Switzerland Artemisinin Revenue (2021-2032) & (US$ Million) Table 158. Sweden Artemisinin Revenue (2021-2032) & (US$ Million) Table 159. Poland Artemisinin Revenue (2021-2032) & (US$ Million) Table 160. China Artemisinin Revenue by Type (2021-2026) & (US$ Million) Table 161. China Artemisinin Revenue by Type (2027-2032) & (US$ Million) Table 162. China Artemisinin Sales by Type (2021-2026) & (MT) Table 163. China Artemisinin Sales by Type (2027-2032) & (MT) Table 164. China Artemisinin Sales Price by Type (2021-2026) & (USD/MT) Table 165. China Artemisinin Sales Price by Type (2027-2032) & (USD/MT) Table 166. China Artemisinin Revenue by Application (2021-2026) & (US$ Million) Table 167. China Artemisinin Revenue by Application (2027-2032) & (US$ Million) Table 168. China Artemisinin Sales by Application (2021-2026) & (MT) Table 169. China Artemisinin Sales by Application (2027-2032) & (MT) Table 170. China Artemisinin Sales Price by Application (2021-2026) & (USD/MT) Table 171. China Artemisinin Sales Price by Application (2027-2032) & (USD/MT) Table 172. Asia Artemisinin Revenue by Type (2021-2026) & (US$ Million) Table 173. Asia Artemisinin Revenue by Type (2027-2032) & (US$ Million) Table 174. Asia Artemisinin Sales by Type (2021-2026) & (MT) Table 175. Asia Artemisinin Sales by Type (2027-2032) & (MT) Table 176. Asia Artemisinin Sales Price by Type (2021-2026) & (USD/MT) Table 177. Asia Artemisinin Sales Price by Type (2027-2032) & (USD/MT) Table 178. Asia Artemisinin Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Artemisinin Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Artemisinin Sales by Application (2021-2026) & (MT) Table 181. Asia Artemisinin Sales by Application (2027-2032) & (MT) Table 182. Asia Artemisinin Sales Price by Application (2021-2026) & (USD/MT) Table 183. Asia Artemisinin Sales Price by Application (2027-2032) & (USD/MT) Table 184. Asia Artemisinin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Asia Artemisinin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Asia Artemisinin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Asia Artemisinin Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 188. Asia Artemisinin Sales by Country (2021-2026) & (MT) Table 189. Asia Artemisinin Sales by Country (2027-2032) & (MT) Table 190. Asia Artemisinin Sales Price by Country (2021-2026) & (USD/MT) Table 191. Asia Artemisinin Sales Price by Country (2027-2032) & (USD/MT) Table 192. Japan Artemisinin Revenue (2021-2032) & (US$ Million) Table 193. South Korea Artemisinin Revenue (2021-2032) & (US$ Million) Table 194. India Artemisinin Revenue (2021-2032) & (US$ Million) Table 195. Australia Artemisinin Revenue (2021-2032) & (US$ Million) Table 196. Taiwan Artemisinin Revenue (2021-2032) & (US$ Million) Table 197. Southeast Asia Artemisinin Revenue (2021-2032) & (US$ Million) Table 198. SAMEA Artemisinin Revenue by Type (2021-2026) & (US$ Million) Table 199. SAMEA Artemisinin Revenue by Type (2027-2032) & (US$ Million) Table 200. SAMEA Artemisinin Sales by Type (2021-2026) & (MT) Table 201. SAMEA Artemisinin Sales by Type (2027-2032) & (MT) Table 202. SAMEA Artemisinin Sales Price by Type (2021-2026) & (USD/MT) Table 203. SAMEA Artemisinin Sales Price by Type (2027-2032) & (USD/MT) Table 204. SAMEA Artemisinin Revenue by Application (2021-2026) & (US$ Million) Table 205. SAMEA Artemisinin Revenue by Application (2027-2032) & (US$ Million) Table 206. SAMEA Artemisinin Sales by Application (2021-2026) & (MT) Table 207. SAMEA Artemisinin Sales by Application (2027-2032) & (MT) Table 208. SAMEA Artemisinin Sales Price by Application (2021-2026) & (USD/MT) Table 209. SAMEA Artemisinin Sales Price by Application (2027-2032) & (USD/MT) Table 210. SAMEA Artemisinin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. SAMEA Artemisinin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. SAMEA Artemisinin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. SAMEA Artemisinin Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 214. SAMEA Artemisinin Sales by Country (2021-2026) & (MT) Table 215. SAMEA Artemisinin Sales by Country (2027-2032) & (MT) Table 216. SAMEA Artemisinin Sales Price by Country (2021-2026) & (USD/MT) Table 217. SAMEA Artemisinin Sales Price by Country (2027-2032) & (USD/MT) Table 218. Brazil Artemisinin Revenue (2021-2032) & (US$ Million) Table 219. Argentina Artemisinin Revenue (2021-2032) & (US$ Million) Table 220. Chile Artemisinin Revenue (2021-2032) & (US$ Million) Table 221. Colombia Artemisinin Revenue (2021-2032) & (US$ Million) Table 222. Peru Artemisinin Revenue (2021-2032) & (US$ Million) Table 223. Saudi Arabia Artemisinin Revenue (2021-2032) & (US$ Million) Table 224. Israel Artemisinin Revenue (2021-2032) & (US$ Million) Table 225. UAE Artemisinin Revenue (2021-2032) & (US$ Million) Table 226. Turkey Artemisinin Revenue (2021-2032) & (US$ Million) Table 227. Iran Artemisinin Revenue (2021-2032) & (US$ Million) Table 228. Egypt Artemisinin Revenue (2021-2032) & (US$ Million) Table 229. Key Raw Materials Table 230. Raw Materials Key Suppliers Table 231. Artemisinin Distributors List Table 232. Artemisinin Customers List Table 233. Research Programs/Design for This Report Table 234. Authors List of This Report Table 235. Secondary Sources Table 236. Primary Sources List of Figures Figure 1. Artemisinin Product Image Figure 2. Global Artemisinin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artemisinin Market Size Share 2021 VS 2025 VS 2032 Figure . Extraction From Artemisia Annua Image Figure 1. Semisynthetic Artemisinin Image Figure 2. Global Artemisinin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artemisinin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Antimalarial Injections Image Figure 5. Antimalarial Tablets Image Figure 6. Global Artemisinin Capacity, Capacity Utilization (2021-2032) & (MT) Figure 7. Global Artemisinin Production by Region: 2021 VS 2025 VS 2032 (MT) Figure 8. Global Artemisinin Production Market Share by Region: 2025 Versus 2032 Figure 9. Global Artemisinin Production Market Share by Region (2021-2032) Figure 10. North America Artemisinin Production Growth Rate (2021-2032) & (MT) Figure 11. Europe Artemisinin Production Growth Rate (2021-2032) & (MT) Figure 12. China Artemisinin Production Growth Rate (2021-2032) & (MT) Figure 13. Japan Artemisinin Production Growth Rate (2021-2032) & (MT) Figure 14. Global Artemisinin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Artemisinin Revenue (2021-2032) & (US$ Million) Figure 16. Global Artemisinin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Artemisinin Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Artemisinin Revenue Market Share by Region (2021-2032) Figure 19. Global Artemisinin Sales (2021-2032) & (MT) Figure 20. Global Artemisinin Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 21. Global Artemisinin Sales Market Share by Region (2021-2032) Figure 22. North America Artemisinin Sales YoY (2021-2032) & (MT) Figure 23. Europe Artemisinin Sales YoY (2021-2032) & (MT) Figure 24. China Artemisinin Sales YoY (2021-2032) & (MT) Figure 25. Asia (Excluding China) Artemisinin Sales YoY (2021-2032) & (MT) Figure 26. South America, Middle East and Africa Artemisinin Sales YoY (2021-2032) & (MT) Figure 27. Global Artemisinin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Artemisinin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Artemisinin Revenue Market Share by Type (2021-2032) Figure 31. Global Artemisinin Sales Market Share by Type (2021-2032) Figure 32. Global Artemisinin Revenue Market Share by Application (2021-2032) Figure 33. Global Artemisinin Sales Market Share by Application (2021-2032) Figure 34. North America Artemisinin Revenue Share by Type (2021-2032) Figure 35. North America Artemisinin Sales Share by Type (2021-2032) Figure 36. North America Artemisinin Revenue Share by Application (2021-2032) Figure 37. North America Artemisinin Sales Share by Application (2021-2032) Figure 38. North America Artemisinin Revenue Share by Country (2021-2032) Figure 39. North America Artemisinin Sales Share by Country (2021-2032) Figure 40. Europe Artemisinin Revenue Share by Type (2021-2032) Figure 41. Europe Artemisinin Sales Share by Type (2021-2032) Figure 42. Europe Artemisinin Revenue Share by Application (2021-2032) Figure 43. Europe Artemisinin Sales Share by Application (2021-2032) Figure 44. Europe Artemisinin Revenue Share by Country (2021-2032) Figure 45. Europe Artemisinin Sales Share by Country (2021-2032) Figure 46. China Artemisinin Revenue Share by Type (2021-2032) Figure 47. China Artemisinin Sales Share by Type (2021-2032) Figure 48. China Artemisinin Revenue Share by Application (2021-2032) Figure 49. China Artemisinin Sales Share by Application (2021-2032) Figure 50. Asia Artemisinin Revenue Share by Type (2021-2032) Figure 51. Asia Artemisinin Sales Share by Type (2021-2032) Figure 52. Asia Artemisinin Revenue Share by Application (2021-2032) Figure 53. Asia Artemisinin Sales Share by Application (2021-2032) Figure 54. Asia Artemisinin Revenue Share by Country (2021-2032) Figure 55. Asia Artemisinin Sales Share by Country (2021-2032) Figure 56. SAMEA Artemisinin Revenue Share by Type (2021-2032) Figure 57. SAMEA Artemisinin Sales Share by Type (2021-2032) Figure 58. SAMEA Artemisinin Revenue Share by Application (2021-2032) Figure 59. SAMEA Artemisinin Sales Share by Application (2021-2032) Figure 60. SAMEA Artemisinin Revenue Share by Country (2021-2032) Figure 61. SAMEA Artemisinin Sales Share by Country (2021-2032) Figure 62. Artemisinin Value Chain Figure 63. Manufacturing Cost Structure Figure 64. Artemisinin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Extraction From Artemisia Annua
  • Semisynthetic Artemisinin
Applications
  • Antimalarial Injections
  • Antimalarial Tablets
Companies covered
  • Sanofi
  • KPC Pharmaceuticals
  • Kerui nanhai
  • Guangxi xiancaotang
  • Guilin Pharmaceutical
  • Natural Bio-engineering
  • BIONEXX
  • CAT KHANH
  • BEEPZ
  • Novanat Bioresource

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Artemisinin Market by Type
  3. 1.2.1 Global Artemisinin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Extraction From Artemisia Annua
  5. 1.2.3 Semisynthetic Artemisinin
  6. 1.3 Artemisinin Market by Application
  7. 1.3.1 Global Artemisinin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Antimalarial Injections
  9. 1.3.3 Antimalarial Tablets
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Artemisinin Market Dynamics
  1. 2.1 Artemisinin Industry Trends
  2. 2.2 Artemisinin Industry Drivers
  3. 2.3 Artemisinin Industry Opportunities and Challenges
  4. 2.4 Artemisinin Industry Restraints
3 Global Artemisinin Production Overview
  1. 3.1 Global Artemisinin Production Capacity (2021-2032)
  2. 3.2 Global Artemisinin Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Artemisinin Production by Region
  4. 3.3.1 Global Artemisinin Production by Region (2021-2026)
  5. 3.3.2 Global Artemisinin Production by Region (2027-2032)
  6. 3.3.3 Global Artemisinin Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Artemisinin Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Artemisinin Revenue by Region
  3. 4.2.1 Global Artemisinin Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Artemisinin Revenue by Region (2021-2026)
  5. 4.2.3 Global Artemisinin Revenue by Region (2027-2032)
  6. 4.2.4 Global Artemisinin Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Artemisinin Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Artemisinin Sales by Region
  9. 4.4.1 Global Artemisinin Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Artemisinin Sales by Region (2021-2026)
  11. 4.4.3 Global Artemisinin Sales by Region (2027-2032)
  12. 4.4.4 Global Artemisinin Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Artemisinin Revenue by Manufacturers
  2. 5.1.1 Global Artemisinin Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Artemisinin Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Artemisinin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Artemisinin Sales by Manufacturers
  6. 5.2.1 Global Artemisinin Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Artemisinin Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Artemisinin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Artemisinin Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Artemisinin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Artemisinin Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Artemisinin Manufacturers, Product Type & Application
  13. 5.7 Global Artemisinin Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Artemisinin Market CR5 and HHI
  16. 5.8.2 2025 Artemisinin Tier 1, Tier 2, and Tier 3
6 Artemisinin Market by Type
  1. 6.1 Global Artemisinin Revenue by Type
  2. 6.1.1 Global Artemisinin Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Artemisinin Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Artemisinin Sales by Type
  5. 6.2.1 Global Artemisinin Sales by Type (2021-2032) & (MT)
  6. 6.2.2 Global Artemisinin Sales Market Share by Type (2021-2032)
  7. 6.3 Global Artemisinin Price by Type
7 Artemisinin Market by Application
  1. 7.1 Global Artemisinin Revenue by Application
  2. 7.1.1 Global Artemisinin Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Artemisinin Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Artemisinin Sales by Application
  5. 7.2.1 Global Artemisinin Sales by Application (2021-2032) & (MT)
  6. 7.2.2 Global Artemisinin Sales Market Share by Application (2021-2032)
  7. 7.3 Global Artemisinin Price by Application
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Artemisinin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Artemisinin Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 KPC Pharmaceuticals
  8. 8.2.1 KPC Pharmaceuticals Company Information
  9. 8.2.2 KPC Pharmaceuticals Business Overview
  10. 8.2.3 KPC Pharmaceuticals Artemisinin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 KPC Pharmaceuticals Artemisinin Product Portfolio
  12. 8.2.5 KPC Pharmaceuticals Recent Developments
  13. 8.3 Kerui nanhai
  14. 8.3.1 Kerui nanhai Company Information
  15. 8.3.2 Kerui nanhai Business Overview
  16. 8.3.3 Kerui nanhai Artemisinin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Kerui nanhai Artemisinin Product Portfolio
  18. 8.3.5 Kerui nanhai Recent Developments
  19. 8.4 Guangxi xiancaotang
  20. 8.4.1 Guangxi xiancaotang Company Information
  21. 8.4.2 Guangxi xiancaotang Business Overview
  22. 8.4.3 Guangxi xiancaotang Artemisinin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Guangxi xiancaotang Artemisinin Product Portfolio
  24. 8.4.5 Guangxi xiancaotang Recent Developments
  25. 8.5 Guilin Pharmaceutical
  26. 8.5.1 Guilin Pharmaceutical Company Information
  27. 8.5.2 Guilin Pharmaceutical Business Overview
  28. 8.5.3 Guilin Pharmaceutical Artemisinin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Guilin Pharmaceutical Artemisinin Product Portfolio
  30. 8.5.5 Guilin Pharmaceutical Recent Developments
  31. 8.6 Natural Bio-engineering
  32. 8.6.1 Natural Bio-engineering Company Information
  33. 8.6.2 Natural Bio-engineering Business Overview
  34. 8.6.3 Natural Bio-engineering Artemisinin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Natural Bio-engineering Artemisinin Product Portfolio
  36. 8.6.5 Natural Bio-engineering Recent Developments
  37. 8.7 BIONEXX
  38. 8.7.1 BIONEXX Company Information
  39. 8.7.2 BIONEXX Business Overview
  40. 8.7.3 BIONEXX Artemisinin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 BIONEXX Artemisinin Product Portfolio
  42. 8.7.5 BIONEXX Recent Developments
  43. 8.8 CAT KHANH
  44. 8.8.1 CAT KHANH Company Information
  45. 8.8.2 CAT KHANH Business Overview
  46. 8.8.3 CAT KHANH Artemisinin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 CAT KHANH Artemisinin Product Portfolio
  48. 8.8.5 CAT KHANH Recent Developments
  49. 8.9 BEEPZ
  50. 8.9.1 BEEPZ Company Information
  51. 8.9.2 BEEPZ Business Overview
  52. 8.9.3 BEEPZ Artemisinin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 BEEPZ Artemisinin Product Portfolio
  54. 8.9.5 BEEPZ Recent Developments
  55. 8.10 Novanat Bioresource
  56. 8.10.1 Novanat Bioresource Company Information
  57. 8.10.2 Novanat Bioresource Business Overview
  58. 8.10.3 Novanat Bioresource Artemisinin Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Novanat Bioresource Artemisinin Product Portfolio
  60. 8.10.5 Novanat Bioresource Recent Developments
9 North America
  1. 9.1 North America Artemisinin Market Size by Type
  2. 9.1.1 North America Artemisinin Revenue by Type (2021-2032)
  3. 9.1.2 North America Artemisinin Sales by Type (2021-2032)
  4. 9.1.3 North America Artemisinin Price by Type (2021-2032)
  5. 9.2 North America Artemisinin Market Size by Application
  6. 9.2.1 North America Artemisinin Revenue by Application (2021-2032)
  7. 9.2.2 North America Artemisinin Sales by Application (2021-2032)
  8. 9.2.3 North America Artemisinin Price by Application (2021-2032)
  9. 9.3 North America Artemisinin Market Size by Country
  10. 9.3.1 North America Artemisinin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Artemisinin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Artemisinin Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Artemisinin Market Size by Type
  2. 10.1.1 Europe Artemisinin Revenue by Type (2021-2032)
  3. 10.1.2 Europe Artemisinin Sales by Type (2021-2032)
  4. 10.1.3 Europe Artemisinin Price by Type (2021-2032)
  5. 10.2 Europe Artemisinin Market Size by Application
  6. 10.2.1 Europe Artemisinin Revenue by Application (2021-2032)
  7. 10.2.2 Europe Artemisinin Sales by Application (2021-2032)
  8. 10.2.3 Europe Artemisinin Price by Application (2021-2032)
  9. 10.3 Europe Artemisinin Market Size by Country
  10. 10.3.1 Europe Artemisinin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Artemisinin Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Artemisinin Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Artemisinin Market Size by Type
  2. 11.1.1 China Artemisinin Revenue by Type (2021-2032)
  3. 11.1.2 China Artemisinin Sales by Type (2021-2032)
  4. 11.1.3 China Artemisinin Price by Type (2021-2032)
  5. 11.2 China Artemisinin Market Size by Application
  6. 11.2.1 China Artemisinin Revenue by Application (2021-2032)
  7. 11.2.2 China Artemisinin Sales by Application (2021-2032)
  8. 11.2.3 China Artemisinin Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Artemisinin Market Size by Type
  2. 12.1.1 Asia Artemisinin Revenue by Type (2021-2032)
  3. 12.1.2 Asia Artemisinin Sales by Type (2021-2032)
  4. 12.1.3 Asia Artemisinin Price by Type (2021-2032)
  5. 12.2 Asia Artemisinin Market Size by Application
  6. 12.2.1 Asia Artemisinin Revenue by Application (2021-2032)
  7. 12.2.2 Asia Artemisinin Sales by Application (2021-2032)
  8. 12.2.3 Asia Artemisinin Price by Application (2021-2032)
  9. 12.3 Asia Artemisinin Market Size by Country
  10. 12.3.1 Asia Artemisinin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Artemisinin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Artemisinin Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Artemisinin Market Size by Type
  2. 13.1.1 SAMEA Artemisinin Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Artemisinin Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Artemisinin Price by Type (2021-2032)
  5. 13.2 SAMEA Artemisinin Market Size by Application
  6. 13.2.1 SAMEA Artemisinin Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Artemisinin Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Artemisinin Price by Application (2021-2032)
  9. 13.3 SAMEA Artemisinin Market Size by Country
  10. 13.3.1 SAMEA Artemisinin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Artemisinin Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Artemisinin Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Artemisinin Value Chain Analysis
  2. 14.1.1 Artemisinin Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Artemisinin Production Mode & Process
  6. 14.2 Artemisinin Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Artemisinin Distributors
  9. 14.2.3 Artemisinin Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst